Results 71 to 80 of about 35,525 (153)

Sodium-glucose co-transporter-2 inhibitors: know the patient and the drugs [PDF]

Hong Kong Medical Journal, 2019
L L, Lim, J C N, Chan
openaire   +2 more sources

Implementing sodium-glucose co-transporter 2 inhibitors in cardiovascular-kidney-metabolic syndrome: a multidisciplinary expert perspective. [PDF]

Eur Heart J Cardiovasc Pharmacother
Avogaro A, Gori M, Grandaliano G, Iacoviello M, Trevisan R.   +4 more
europepmc   +1 more source

Sodium-glucose co-transporter 2 inhibitors are negatively correlated with hypomagnesemia in elderly patients with type 2 diabetes. [PDF]

Front Nutr
Lin L, Jin Y, Jin L, Wang B, Xu J, Chen S.   +5 more
europepmc   +1 more source

Early initiation of sodium-glucose co-transporter-2 inhibitors in heart failure patients: a nationwide study. [PDF]

ESC Heart Fail
Gautier P, Lafaurie M, Bouisset F, Delmas C, Cherbi M, Lhermusier T, Elbaz M, Montastruc F.   +7 more
europepmc   +1 more source

Sodium-Glucose Co-Transporter 2 Inhibitors' Use in Muscular Dystrophy-Related Cardiomyopathy: Data from a Single-Center Experience. [PDF]

J Clin Med
Matassini MV, Coraducci F, Mancini N, Campanella F, Carabotta C, Shkoza M, Pettinari L, Coccia M, Russo AD, Marini M.   +9 more
europepmc   +1 more source

Cost-Effectiveness of Sodium-Glucose Co-Transporter-2 Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors by Ejection Fraction and Drug Pricing in the United States: A Systematic Review. [PDF]

Circ Popul Health Outcomes
Alfie TJ, Wasfy JH, Kazi DS, Januzzi JL, Bellows BK, Cohen LP.   +5 more
europepmc   +1 more source

The preventive effect of sodium-glucose co-transporter-2 inhibitors on life-threatening arrhythmias in patients with chronic kidney disease: a meta-analysis. [PDF]

Front Cardiovasc Med
Yang Q, Jia Y, Li Z, Yu Y, Dang Y.
europepmc   +1 more source

Sodium Glucose Co-Transporter 2 Inhibitors in Patients With Heart Failure and Transcatheter Aortic Valve Replacement. [PDF]

JACC Adv
Yasmin F, Hamza M, Fahim MAA, Asghar MS, Ullah W, Alraies MC.   +5 more
europepmc   +1 more source

Fournier's gangrene and sodium-glucose co-transporter 2(SGLT2) inhibitors: Our experience

Indian Journal of Endocrinology and Metabolism, 2019
Ashwitha S Dass, Gloria Immaculate, Arpandev Bhattacharyya   +2 more
doaj   +1 more source

Sodium-glucose co-transporter 2 inhibitors and obesity-associated cancers in people with type 2 diabetes: A real-world observational study. [PDF]

Diabetes Obes Metab
Ipaye T, Goldney J, Yates T, Zaccardi F, Khunti K, Akalestou E, Davies MJ, Brown K, Papamargaritis D.   +8 more
europepmc   +1 more source